-
Study aim
-
Clinical evaluation of a new silicone mold for producing dynamic spacers during knee surgery
-
Design
-
The clinical trial has a control group and a parallel group that is double-blind and non-randomized and the patients are matched. The patients are followed up for one year after the operation, and the range of motion of the knee, the level of function and diagnostic biomarkers of infection are measured in the time intervals of 1 month, 3 months, 6 months and 1 year after the operation.
-
Settings and conduct
-
The study is conducted in the hospitals of Bojnurd, the patients are divided into two groups, these groups are matched in terms of age, sex, weight and co-morbidities. The study is double-blind, and a person who does not know the type of spacer used for the patient will perform examinations and measurement of variables .
-
Participants/Inclusion and exclusion criteria
-
Entry criteria: patients with artificial joint infection. The diagnostic criteria for current knee infection for inclusion in this study are one or more of the following: aspiration of infectious synovial fluid (determined by differential count of the number of white blood cells and the percentage of polymorphonuclear leukocytes), isolation of organism(s) from synovial fluid , presence of a draining sinus, or MRI evidence of a septic arthritis with osteomyelitis. Exit criteria: None
-
Intervention groups
-
The patients are divided into two groups, one receives spacers produced manually, these spacers are made manually from bone cement and antibiotics. And the other group receives the spacers that were produced with a mold, antibiotic cement will be poured into this device and after forming, it will be placed in the knee space during surgery.
-
Main outcome variables
-
physical function and life quality